| Entry |
|
|---|
| Name |
Lisofylline (USAN/INN);
ProTec (TN) |
|---|
| Formula |
C13H20N4O3
|
|---|
| Exact mass |
280.1535
|
|---|
| Mol weight |
280.3229
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Immunological agent
DG02019 Interleukin inhibitor
Respiratory system agent
DG01616 Xanthine derivative
|
|---|
| Efficacy |
Immunomodulator |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Immunological agent
DG02019 Interleukin inhibitor
D04748 Lisofylline
Respiratory system agent
DG01616 Xanthine derivative
D04748 Lisofylline
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Interleukins
IL12
D04748 Lisofylline (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 20
1 C8y C 37.8781 -24.9679
2 C8y C 37.8781 -26.3931
3 C8y C 39.0813 -24.2611
4 N4y N 36.5754 -24.5357
5 N4y N 39.0813 -27.0767
6 N5x N 36.5754 -26.8254
7 N4y N 40.3022 -24.9971
8 O5x O 39.0813 -22.8825
9 C8x C 35.7576 -25.6922
10 C1a C 36.1374 -23.2096
11 C8y C 40.3022 -26.3406
12 C1a C 39.0813 -28.5077
13 C1b C 41.5170 -24.3078
14 O5x O 41.5522 -27.0416
15 C1b C 42.7205 -25.0030
16 C1b C 43.9296 -24.3021
17 C1b C 45.1329 -25.0030
18 C1c C 46.3419 -24.3021
19 C1a C 47.5511 -25.0030
20 O1a O 46.3412 -22.8713
BOND 21
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 4 10 1
10 5 11 1
11 5 12 1
12 7 13 1
13 11 14 2
14 13 15 1
15 15 16 1
16 16 17 1
17 17 18 1
18 18 19 1
19 6 9 2
20 7 11 1
21 18 20 1 #Down
|
|---|
